210 related articles for article (PubMed ID: 29212911)
1. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes.
Białoszewska A; Olkowska-Truchanowicz J; Bocian K; Osiecka-Iwan A; Czop A; Kieda C; Malejczyk J
J Immunol; 2018 Jan; 200(2):715-724. PubMed ID: 29212911
[TBL] [Abstract][Full Text] [Related]
2. Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.
Rosen DB; Cao W; Avery DT; Tangye SG; Liu YJ; Houchins JP; Lanier LL
J Immunol; 2008 May; 180(10):6508-17. PubMed ID: 18453569
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor.
Rosen DB; Bettadapura J; Alsharifi M; Mathew PA; Warren HS; Lanier LL
J Immunol; 2005 Dec; 175(12):7796-9. PubMed ID: 16339513
[TBL] [Abstract][Full Text] [Related]
4. NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity.
Grazia Cifone M; Roncaioli P; Cironi L; Festuccia C; Meccia A; D'Aló S; Botti D; Santoni A
J Immunol; 1997 Jul; 159(1):309-17. PubMed ID: 9200468
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
[TBL] [Abstract][Full Text] [Related]
6. Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes.
Białoszewska A; Baychelier F; Niderla-Bielińska J; Czop A; Debré P; Vieillard V; Kieda C; Malejczyk J
Cell Immunol; 2013; 285(1-2):6-9. PubMed ID: 24044960
[TBL] [Abstract][Full Text] [Related]
7. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity.
Ryan JC; Niemi EC; Nakamura MC; Seaman WE
J Exp Med; 1995 May; 181(5):1911-5. PubMed ID: 7722466
[TBL] [Abstract][Full Text] [Related]
8. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.
Lanier LL; Chang C; Phillips JH
J Immunol; 1994 Sep; 153(6):2417-28. PubMed ID: 8077657
[TBL] [Abstract][Full Text] [Related]
9. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.
Bennett IM; Zatsepina O; Zamai L; Azzoni L; Mikheeva T; Perussia B
J Exp Med; 1996 Nov; 184(5):1845-56. PubMed ID: 8920872
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
[TBL] [Abstract][Full Text] [Related]
11. The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.
Tanaka M; Fine JH; Kirkham CL; Aguilar OA; Belcheva A; Martin A; Ketela T; Moffat J; Allan DSJ; Carlyle JR
Cancer Res; 2018 Jul; 78(13):3589-3603. PubMed ID: 29691253
[TBL] [Abstract][Full Text] [Related]
12. Differentially induced expression of C-type lectins in activated lymphocytes.
Eichler W; Ruschpler P; Wobus M; Drössler K
J Cell Biochem Suppl; 2001; Suppl 36():201-8. PubMed ID: 11455585
[TBL] [Abstract][Full Text] [Related]
13. LLT1-CD161 Interaction in Cancer: Promises and Challenges.
Braud VM; Meghraoui-Kheddar A; Elaldi R; Petti L; Germain C; Anjuère F
Front Immunol; 2022; 13():847576. PubMed ID: 35185935
[TBL] [Abstract][Full Text] [Related]
14. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells.
Yu S; Zhu Y; Chen Z; Alheim M; Ljungberg A; Zhu J
J Neurosci Res; 2002 Mar; 67(6):823-8. PubMed ID: 11891797
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J
Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118
[TBL] [Abstract][Full Text] [Related]
16. High-level expression and purification of soluble form of human natural killer cell receptor NKR-P1 in HEK293S GnTI
Bláha J; Kalousková B; Skořepa O; Pažický S; Novák P; Vaněk O
Protein Expr Purif; 2017 Dec; 140():36-43. PubMed ID: 28757467
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).
Kamishikiryo J; Fukuhara H; Okabe Y; Kuroki K; Maenaka K
J Biol Chem; 2011 Jul; 286(27):23823-30. PubMed ID: 21572041
[TBL] [Abstract][Full Text] [Related]
18. LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.
Bambard ND; Mathew SO; Mathew PA
Scand J Immunol; 2010 Mar; 71(3):210-9. PubMed ID: 20415786
[TBL] [Abstract][Full Text] [Related]
19. Genetic investigation of MHC-independent missing-self recognition by mouse NK cells using an in vivo bone marrow transplantation model.
Chen P; Aguilar OA; Rahim MM; Allan DS; Fine JH; Kirkham CL; Ma J; Tanaka M; Tu MM; Wight A; Kartsogiannis V; Gillespie MT; Makrigiannis AP; Carlyle JR
J Immunol; 2015 Mar; 194(6):2909-18. PubMed ID: 25681346
[TBL] [Abstract][Full Text] [Related]
20. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B.
Li J; Rabinovich BA; Hurren R; Shannon J; Miller RG
Int Immunol; 2003 Mar; 15(3):411-6. PubMed ID: 12618485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
